| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/20/2010 | US7759355 administering a xanthine derivative such as (E)-8-(3,4-dimethoxystyryl)-1,3-diethyl-7-methylxanthine |
| 07/20/2010 | US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus |
| 07/20/2010 | CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 07/15/2010 | WO2010079668A1 Olefin compound |
| 07/15/2010 | WO2010078833A1 Modified sodium-montmorillonite, preparing method and uses thereof |
| 07/15/2010 | WO2010078703A1 Process for preparation of tolterodine and its l-tartrate |
| 07/15/2010 | WO2010045755A8 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 07/15/2010 | US20100179203 Novel pyrazole derivatives useful as potassium channel modulators |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179128 Xanthine derivatives as selective hm74a agonists |
| 07/15/2010 | US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids |
| 07/15/2010 | US20100178344 Extended-Release Composition Comprising a Somatostatin Derivative in Microparticles |
| 07/15/2010 | US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma |
| 07/15/2010 | US20100176340 Buffered compositions for dialysis |
| 07/14/2010 | EP2206772A2 Method of collecting placental stem cells |
| 07/14/2010 | EP2206720A1 Albumin fusion proteins |
| 07/14/2010 | EP2206707A1 Azolecarboxamide compound or salt thereof |
| 07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
| 07/14/2010 | EP1486494B1 N-substituted benzothiophenesulfonamide derivative |
| 07/14/2010 | CN101775026A Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof |
| 07/14/2010 | CN101773620A Heat-clearing stranguria-treating drug |
| 07/14/2010 | CN101773592A Method fro controlling quality of pill of six ingredients with rehmannia |
| 07/14/2010 | CN101773542A Medicine for treating prostatic diseases and preparation method thereof |
| 07/14/2010 | CN101773541A Yupingfeng soft capsule |
| 07/14/2010 | CN101773515A Preparation methods of creatinine absorbent |
| 07/14/2010 | CN101773497A Compound alpha-keto acid tablet and preparation method thereof |
| 07/14/2010 | CN101164592B Traditional Chinese medicine extract for treating chronic nephritis, capsule and preparation method |
| 07/14/2010 | CN101100463B Benzofuran derivative and application thereof |
| 07/13/2010 | US7754856 Human sodium-dependent bile acid transporter proteins |
| 07/13/2010 | US7754751 Preferential inhibition of release of pro-inflammatory cytokines |
| 07/13/2010 | US7754750 a -5 substituted 1-H,3-H-imidazolidine-2,4-dione such as 5-(2-{[4-(4'-fluoro[1,1'-biphenyl]-4-yl)-1-piperazinyl]sulfonyl}ethyl)-2,4-imidazolidinedione; protease inhibitors, especially metalloelastase (MMP12) |
| 07/13/2010 | US7754735 such as 3-(2-chloro-4-quinolinyl)-2,5-dimethyl-1H-indole-1-acetic acid, used for treating respiratory system disorders and as inhibitors of G protein-coupled receptor chemoattractant homologous receptor expressed on lymphocyte cells (CRTH2) |
| 07/13/2010 | US7754228 Cytotoxic T-cell epitopes from Chlamydia |
| 07/13/2010 | US7754200 Phosphate transport inhibitors |
| 07/13/2010 | CA2514022C Reduced dose of tolterodine and other antimuscarinic agents for treating urinary disorders |
| 07/13/2010 | CA2505910C Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 07/13/2010 | CA2446820C Novel pyrrole derivatives as pharmaceutical agents |
| 07/13/2010 | CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives |
| 07/13/2010 | CA2430539C Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 07/13/2010 | CA2345932C Peptide-based carrier devices for stellate cells |
| 07/13/2010 | CA2176742C Composition for the in vivo production of therapeutic products |
| 07/08/2010 | WO2010078324A2 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/08/2010 | WO2010078319A1 Lipoic acid containing compositions for use in the treatment and prevention of ki dney- related disorders in companion animals |
| 07/08/2010 | WO2010077935A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals |
| 07/08/2010 | WO2010077883A2 Antagonists of lysophosphatidic acid receptors |
| 07/08/2010 | WO2010077741A1 Diagnosis and therapy of organ dysfunction using sphinganine-1-phosphate |
| 07/08/2010 | US20100173972 Methods and uses related to rhbdl4 |
| 07/08/2010 | US20100173947 New Indications for Direct Thrombin Inhibitors |
| 07/08/2010 | US20100173946 Benzimidazolylidene propane-1,3-dione derivative or salt thereof |
| 07/08/2010 | US20100173929 Tricyclic N-heteroaryl-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/08/2010 | US20100173919 Pharmaceutical composition using aliskiren and avosentan |
| 07/08/2010 | US20100173884 Use of a phytosterol containing composition for the treatment of luts |
| 07/08/2010 | US20100173878 Organic compounds |
| 07/08/2010 | US20100173841 Highly Purified Type A Botulinum Toxin Preparation From Infant Botulism Pathogen |
| 07/08/2010 | US20100173823 Alpha2c adrenoreceptor agonists |
| 07/08/2010 | US20100172988 Sustained release preparation and method for production thereof |
| 07/08/2010 | US20100172975 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 07/08/2010 | US20100172914 Methods and materials related to trail isoforms |
| 07/08/2010 | US20100170849 Buffered compositions for dialysis |
| 07/08/2010 | CA2823331A1 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/08/2010 | CA2746811A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals |
| 07/08/2010 | CA2746139A1 Companion animal compositions including lipoic acid and methods of use thereof |
| 07/08/2010 | CA2744221A1 Antagonists of lysophosphatidic acid receptors |
| 07/07/2010 | EP2204192A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 07/07/2010 | EP2204181A2 Protease inhibitors |
| 07/07/2010 | EP2203170A1 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 07/07/2010 | EP1873153B1 3-azetidinecarboxylic acid derivatives for use as immunosuppressants |
| 07/07/2010 | EP1487806B1 4-anilino quinazoline derivatives as antiproliferative agents |
| 07/07/2010 | EP1485099B1 Inhibitors of histone deacetylase |
| 07/07/2010 | CN101772499A Tricyclic N-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same |
| 07/07/2010 | CN101766777A Chinese medicine composite for treating chronic renal failure |
| 07/07/2010 | CN101766739A Chinese medicine for treating lithangiuria and preparation method thereof |
| 07/07/2010 | CN101766734A Medicine for treating prostatitis |
| 07/07/2010 | CN101766678A Application of total flavonoid in astragalus to preparing medicaments for preventing and controlling diabetes and nephropathy |
| 07/07/2010 | CN101766651A Purpose of corbicula water extract |
| 07/07/2010 | CN101766645A Creatinine sorbent |
| 07/07/2010 | CN101766574A Preparation formulations of sodium pyruvate freeze-dried powder injection, injection and solid agent and production processes thereof |
| 07/07/2010 | CN101152407B Medicament for treating chronic prostatitis and method of preparing the same |
| 07/07/2010 | CN101028349B Externally-applied medicine for treating prostatitis and prostatic accrementition and preparation method thereof |
| 07/06/2010 | US7750150 Process for producing acid adduct salt of polyacidic base compound |
| 07/06/2010 | US7750029 administering (R)-2-(2-aminothiazol-4-yl)-4'-[2-[(2-hydroxy-2-phenylethyl)amino]ethyl]acetic acid anilide; treating urogenital disorders |
| 07/06/2010 | US7750023 Quinuclidine derivatives and medicinal compositions containing the same |
| 07/06/2010 | US7749998 urotensin antagonists such as N-[1-(4-biphenyl)-1)-2-(1-pyrrolidinyl)ethyl]-2-(6,7-dichloro-3-oxo-2,3-dihydro-4H-1,4-benzoxazin-4-yl)-N-methylacetamide, used for treating congestive heart failure, stroke, ischemia, angina, overactive bladder or arrhythmia |
| 07/06/2010 | US7749991 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 07/06/2010 | US7749960 An enteral composition or a pharmaceutical containing osteoprotegerin obtained from human or bovine milk or colostrum; preventing or treating disorders associated with bone metabolism and immune function |
| 07/06/2010 | CA2454863C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 07/06/2010 | CA2446149C Vitamin d analogues |
| 07/06/2010 | CA2415962C Valsartan salts |
| 07/06/2010 | CA2370814C Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 07/01/2010 | WO2010075263A2 Compounds and methods for enhancing erythropoiesis |
| 07/01/2010 | WO2010074193A1 Novel bicyclic heterocyclic compound |
| 07/01/2010 | WO2010073642A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 07/01/2010 | WO2010043408A3 Microencapsulated fesoterodine |
| 07/01/2010 | WO2010037050A3 Synthesis of functionalized octahydro-isoquinolin-1-one-8-carboxamides, octahydro-isoquinolin-1-one-8-carboxylic esters and analogs, and therapeutic methods |
| 07/01/2010 | WO2010036567A3 Harmine compounds for promoting bone growth |
| 07/01/2010 | US20100168232 Oligomer-Anticholinergic Agent Conjugates |
| 07/01/2010 | US20100168196 N-Substituted (Benzoimidazol-2-yl)phenylamines, Processes for Their Preparation, Their Use as a Medicament or Diagnostic Aid, and a Medicament Comprising Them |
| 07/01/2010 | US20100168193 Therapeutic use of imidazole-5-carboxylic acid derivatives |